GPT and metabolic dysfunction-associated steatotic liver disease: These biomarkers also facilitate investigations into their potential links with liver health indicators, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), total bilirubin, and metabolic dysfunction-associated steatotic liver disease (MASLD).